» Articles » PMID: 9389510

Positive and Negative Regulation of the Rat Vasopressin Gene Promoter

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1997 Dec 6
PMID 9389510
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

To study the transcriptional regulation of the vasopressin gene in vitro, 3 kb of the 5' regulatory region of the rat vasopressin gene was isolated and subcloned, along with a series of various deletion mutants, into vectors containing the luciferase reporter gene. After transfecting these genes transiently into the human choriocarcinoma cell line JEG-3 along with a glucocorticoid receptor (GR) expression vector, transcriptional activity was quantitated using the luciferase assay. Forskolin, 8-bromo-cAMP, and protein kinase A catalytic subunit expression all markedly increased transcription from the 3-kb promoter. Analyses with deletion mutants of the promoter showed that two cAMP-responsive element (CRE)-like sequences (-227 to -220 bp and -123 to -116 bp) contribute to this positive regulation. Expression of KCREB, a dominant negative mutant of the cAMP-responsive element binding protein (CREB), suggested the involvement of CREB. Transfection of the activator protein 2 (AP2) DNA consensus sequence partially blocked transcription. Dexamethasone suppressed forskolin-stimulated expression. The negative effect of glucocorticoid was GR dependent and may be mediated by a mechanism not involving GR binding to DNA because it was independent of the putative glucocorticoid-responsive element previously reported in the vasopressin promoter (-622 to -608 bp) and was preserved in the shorter promoter constructs in which no glucocorticoid-responsive element-like sequence was found. Our data suggest that several trans-acting factors including CREB, AP2, and GR are likely to be involved in vasopressin gene transcription and that the positive and negative regulation of vasopressin gene transcription is complex.

Citing Articles

The Interaction of Vasopressin with Hormones of the Hypothalamo-Pituitary-Adrenal Axis: The Significance for Therapeutic Strategies in Cardiovascular and Metabolic Diseases.

Szczepanska-Sadowska E, Czarzasta K, Bogacki-Rychlik W, Kowara M Int J Mol Sci. 2024; 25(13).

PMID: 39000501 PMC: 11242374. DOI: 10.3390/ijms25137394.


Vasopressin Expressed in Hypothalamic CRF Neurons Causes Impaired Water Diuresis in Secondary Adrenal Insufficiency.

Yamagata S, Talukder A, Murasawa S, Niioka K, Kumagai N, Takagi M Endocrinology. 2023; 164(8).

PMID: 37450603 PMC: 10373949. DOI: 10.1210/endocr/bqad109.


The Biology of Vasopressin.

Sparapani S, Millet-Boureima C, Oliver J, Mu K, Hadavi P, Kalostian T Biomedicines. 2021; 9(1).

PMID: 33477721 PMC: 7832310. DOI: 10.3390/biomedicines9010089.


TRIIODOTHYRONINE ACTIVATES GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE 3 VIA AGGTCA-LIKE-DIRECT-REPEAT-4 TYPE THYROID HORMONE RESPONSE ELEMENT.

Zhao L, Iwasaki Y, Han B, Wang J, Zhang Y, Han J Acta Endocrinol (Buchar). 2020; 16(2):129-135.

PMID: 33029227 PMC: 7535892. DOI: 10.4183/aeb.2020.129.


Genome-Wide Analysis of Glucocorticoid-Responsive Transcripts in the Hypothalamic Paraventricular Region of Male Rats.

Itoi K, Motoike I, Liu Y, Clokie S, Iwasaki Y, Uchida K Endocrinology. 2018; 160(1):38-54.

PMID: 30364965 PMC: 6302960. DOI: 10.1210/en.2018-00535.